Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Creative Biogene's plasmid copy number (PCN) testing service accurately determines the average plasmid copies per host cell in recombinant engineered bacteria. PCN controls gene dosage, directly impacting recombinant protein expression and batch-to-batch consistency. The service offers three technical routes (qPCR, ddPCR, and chip-based dPCR) for flexible selection based on product stage, sensitivity, and regulatory needs. Creative Biogene provides one-stop support from MCB vs EOPC comparison to a complete genetic stability data package, covering full-lifecycle copy number monitoring from IND to commercial manufacturing.
Plasmid copy number (PCN) is defined as the average number of target plasmid molecules carried per host cell. Plasmids are generally classified into low copy (~15-20 copies/cell), medium copy (~20-100 copies/cell), and high copy (100 – several hundred copies/cell). Precise control of copy number is critically important in several application scenarios:
Creative Biogene offers three mainstream technical routes for plasmid copy number detection, differentiated by absolute quantification precision, sensitivity, throughput, and cost.
Absolute Quantification qPCR
A standard curve of known copy number is prepared using plasmid DNA standards (typically 5-7 concentration gradients covering a 5-6 log dynamic range). The sample is simultaneously analyzed by real-time qPCR for a plasmid target gene (e.g., antibiotic resistance gene, origin of replication sequence, GOI) and a host single-copy reference gene (e.g., 16S rDNA, recA, gapDH). The absolute plasmid copy number per host genome is calculated using the ΔCt method.
Droplet Digital PCR (ddPCR)
The PCR reaction mixture is partitioned into tens of thousands of independent droplets (typically 20,000 per sample), each containing zero or one target DNA molecule. After PCR amplification, the proportion of positive droplets is analyzed using Poisson statistics to directly calculate the absolute copy number of the target DNA molecule – completely independent of a standard curve.
Chip-Based Digital PCR (dPCR)
dPCR and ddPCR are statistically identical – both achieve single-molecule counting and Poisson-based quantitation by partitioning the sample into a large number of independent reaction chambers. The difference lies in the physical partitioning method: ddPCR uses water-in-oil droplet emulsions, while dPCR uses physical chips/microwell plates, with each microwell serving as an independent reaction chamber.
Method Selection Matrix
| Aspect | qPCR | ddPCR | dPCR (Chip-Based) |
| Partitioning principle | No partitioning (bulk amplification) | Water-in-oil droplets | Physical chip/nanoplate |
| Quantitation method | Relative (standard curve) | Absolute | Absolute |
| Standard requirement | Required (major error source) | Not required (only positive control) | Not required |
| Sensitivity | Moderate (10-100 copies) | High (single copy) | High (single copy) |
| Inhibitor tolerance | Low | High | High |
| Multiplexing capacity | 4-6 colors (real-time) | 2 colors | 4-5 colors |
| Throughput | High (384-well rapid) | Medium (96-well) | Medium-High (96-384-well) |
| Turnaround time | 2-3 hours | 3-4 hours | 1.5-2.5 hours |
| Document | Relevant Section | Key Requirements |
| ICH Q5B: Genetic Stability | Whole document | Requires analysis of cell substrate genetic stability at both MCB and EOPC time points; copy number of the transgene must be determined, and its integrity and integration pattern confirmed by restriction mapping. |
| FDA CMC Guidance for Human Gene Therapy IND (2020) | Section IV: Characterization of Cell Substrates | Requires genetic characterization of cell substrates used for production, including vector copy number (VCN) analysis. |
| BioPhorum Plasmid Release Specifications | Platform Testing Framework | Proposes copy number testing as a recommended method (qPCR/dPCR) for plasmid MCB and plasmid DNA release. |
| NIST VCN Reference Materials Study | Interlaboratory Assessment (2025) | 12 laboratories participated; qPCR, dPCR, and NGS methods all successfully identified VCN standards. |
For detailed technical discussions on copy number stability testing strategies, method validation plans, or IND submission support for your product-specific stage, please contact the Creative Biogene technical team for customized solutions.
Q1: How should I choose between qPCR, ddPCR, and dPCR?
A: The decision depends on three factors: (1) Baseline copy number – low copy (<20 copies/cell) favors ddPCR/dPCR for better precision; (2) Tolerance for standard curve error – for IND submissions requiring highest confidence absolute quantitation, ddPCR/dPCR eliminate the error source of standard value assignment; (3) Sample throughput – for>96 samples/day with high copy numbers, qPCR offers the highest throughput and lowest cost. Creative Biogene offers method pre-evaluation services to help clients determine the optimal platform before project initiation.
Q2: How should acceptance criteria for plasmid copy number be set?
A: Acceptance criteria should follow a risk-based decision logic: (1) Collect copy number data from at least 3 GMP batches of MCB to establish a baseline range; (2) Measure copy number for EOPC (passage number that reflects full production process) for the same three batches, calculate MCB vs EOPC variation; (3) Consider literature and industry consensus (e.g., ±35% for low copy, ±20-30% for medium-high copy as alert limits); (4) Propose acceptance criteria in the IND based on the above data (Phase I criteria may be relatively flexible but scientifically justified, e.g., "EOPC copy number variation relative to MCB ≤2-fold" or "CV ≤30%"). Note: Absolute copy number may vary between batches, but the MCB vs EOPC variation within a batch is the true indicator of genetic stability.
Q3: What should be done when copy number results are lower than expected or show high inter-batch variability?
A: Three steps: First, technical investigation – confirm gDNA extraction efficiency (spike recovery), PCR inhibitors (spike control), and standard curve accuracy (if using qPCR). If using ddPCR/dPCR, check droplet/microwell generation quality and positive/negative separation. Second, biological investigation – evaluate consistency of culture conditions (medium, temperature, passage number) for the host strain during MCB establishment and EOPC sampling; verify whether the plasmid's origin of replication type (pUC ori high copy vs pSC101 ori low copy) is appropriate for the expression system; confirm absence of plasmid multimers by agarose gel electrophoresis. Third, decision – if technical and does not affect product quality, correct, retest, and document the deviation; if genuine biological variation, reassess the genetic stability of the host strain/plasmid combination – this may require re-cloning or adjusting the maximum passage number in the production process.
Q4: Is GMP compliance required for plasmid copy number testing?
A: It depends on the purpose. For MCB and EOPC genetic stability testing intended for IND submission, testing should be performed under GMP-like or GLP conditions to ensure data integrity, traceability, and regulatory acceptability. Key requirements include: use of validated methods (per ICH Q2), establishment and documentation of system suitability criteria, use of calibrated instruments, and retention of complete audit trails for raw data and analysis records. Creative Biogene offers GLP/cGMP-aligned copy number testing services; all methods are fully validated, and data are directly usable for the CMC section of IND submissions.
Copyright © 2026 Creative Biogene. All rights reserved.